Arş. Gör. Dr. MÜFİDE OKAY

Yayın Ağı

Makaleler 25

1. Endocrine Disorders in Adult Beta-Thalassemia Patients: Insights from a Long-Term Follow-Up

Oğuz S. H., OKAY M., FEDAİ A. B., ÜNAL Ş., GÜMRÜK F., SAYINALP N., et al.

Endocrinology Research and Practice , cilt.27, sa.4, ss.205-212, 2023 (Scopus, TRDizin)

2. Clonal B-cell proliferations developing in the background of primary cutaneous CD4(+) small/medium T-cell lymphoproliferative disorder: A case series

Ozdemir D. A., AKDOĞAN N., Okay M., ÜNER A., Saglam A.

JOURNAL OF CUTANEOUS PATHOLOGY , cilt.49, sa.11, ss.971-977, 2022 (SCI-Expanded, Scopus)

3. First report of t(1;15)(q21;q11.2) and t(1;21)(q21;q11.2) anomalies in Burkitt Lymphoma

Bozkurt S., OKAY M., Haznedaroglu C. I.

KUWAIT MEDICAL JOURNAL , cilt.53, sa.3, ss.344-345, 2021 (SCI-Expanded)

4. Protein Kinases in Hematological Disorders

OKAY M., HAZNEDAROĞLU İ. C.

PROTEIN KINASE-MEDIATED DECISIONS BETWEEN LIFE AND DEATH , cilt.1275, ss.383-393, 2021 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

5. Incidence and risk factors for hepatic sinusoidal obstruction syndrome after allogeneic hematopoietic stem cell transplantation: A retrospective multicenter study of Turkish hematology research and education group (ThREG)

SOYER N., Gunduz M., Tekgunduz E., Deveci B., Ozdogu H., ŞAHİN H. H., et al.

TRANSFUSION AND APHERESIS SCIENCE , cilt.59, sa.4, 2020 (SCI-Expanded, Scopus)

6. Richter's transformation in patients with chronic lymphocytic leukemia: a cohort study about risk factors

OKAY M., GÜNEŞ G., Malkan Ü. Y., Heziyev T., GÖKER H., HAZNEDAROĞLU İ. C., et al.

LEUKEMIA & LYMPHOMA , cilt.61, ss.50-52, 2020 (SCI-Expanded, Scopus)

7. Predictive factors for stem cell mobilization failure in multiple myeloma patients: A single center experience

GÖKER H., Ciftciler R., DEMİROĞLU H., Turgut M., SAYINALP N., Haznedaroglu I. C., et al.

TRANSFUSION AND APHERESIS SCIENCE , cilt.59, sa.1, 2020 (SCI-Expanded, Scopus)

8. Ankaferd Hemostat Affects Etoposide Resistance of the Malignant Melanoma Cells

Ghasemi M., OKAY M., Malkan Ü. Y., TÜRK S., Jabbar J., Hocaoglu H., et al.

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , cilt.30, sa.1, ss.43-53, 2020 (SCI-Expanded, Scopus, TRDizin) Sürdürülebilir Kalkınma

9. Splenic Marginal Zone Lymphoma in Turkey: Association with Hepatitis B Instead of Hepatitis C Virus as an Etiologic and Possible Prognostic Factor - A Multicenter Cohort Study

OKAY M., Aslan T., Ozdemir E., ÜNER A., Saglam A., Gungor E., et al.

TURKISH JOURNAL OF HEMATOLOGY , cilt.37, sa.2, ss.84-90, 2020 (SCI-Expanded, Scopus, TRDizin)

10. Patterns of Hydroxyurea Prescription and Use in Routine Clinical Management of Polycythemia Vera: A Multicenter Chart Review Study

BÜYÜKAŞIK Y., ALİ R., Turgut M., SAYDAM G., Yavuz S., ÜNAL A., et al.

TURKISH JOURNAL OF HEMATOLOGY , cilt.37, sa.3, ss.177-185, 2020 (SCI-Expanded, Scopus, TRDizin)

11. Mantle cell lymphoma: a Turkish Multi-Center Study

OKAY M., MELETLİ Ö., KELKİTLİ E., Malkan Ü. Y., Turgut M., BÜYÜKAŞIK Y., et al.

JOURNAL OF BUON , cilt.24, sa.5, ss.2084-2089, 2019 (SCI-Expanded, Scopus)

12. DETERMINANTS OF CARDIORESPIRATORY FITNESS LEVEL IN HEMATOPOIETIC STEM CELL TRANSPLANTATION CANDIDATES

YILDIZ KABAK V., GÖKER H., ATASAVUN UYSAL S., DEMİROĞLU H., ALADAĞ KARAKULAK E., OKAY M., et al.

TURKISH JOURNAL OF PHYSIOTHERAPY REHABILITATION-TURK FIZYOTERAPI VE REHABILITASYON DERGISI , cilt.30, sa.2, ss.81-88, 2019 (ESCI, Scopus, TRDizin)

13. TKI-Related Platelet Dysfunction Does Not Correlate With Bleeding in Patients With Chronic Phase-Chronic Myeloid Leukemia With Complete Hematological Response

Sener Y., OKAY M., Aydin S., BÜYÜKAŞIK Y., AKBIYIK F., DİKMEN Z. G.

CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS , cilt.25, 2019 (SCI-Expanded, Scopus)

14. The impact of At1r inhibition via losartan on the anti-leukaemic effects of doxorubicin in acute myeloid leukaemia

Ghasemi M., OKAY M., TÜRK S., Naeemaee R., Guver E., Malkan Ü. Y., et al.

JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM , cilt.20, sa.2, 2019 (SCI-Expanded, Scopus)

15. The Impact of AT1R Inhibition via Losartan on the Anti-Leukemic Effects of Doxorubicin in Acute Myeloid Leukemia.

GHASEMİ m., OKAY M., TÜRK S., HAZNEDAROĞLU İ. C., AKSU S., SAYINALP N., et al.

Journal Of The Renin-Angiotensin-Aldosterone System , 2019 (SCI-Expanded, Scopus)

16. The Antithrombin Effect of Ankaferd Hemostat (ABS) Is Related to the High Iron Content of the Medicine

OKAY M., Ozturk Y., HAZNEDAROĞLU İ. C.

CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS , cilt.25, 2019 (SCI-Expanded, Scopus)

17. Mitoxantrone-melphalan conditioning regimen for autologous stem cell transplantation in relapsed/refractory lymphoma

OKAY M., BÜYÜKAŞIK Y., DEMİROĞLU H., Malkan Ü. Y., Ciftciler R., ALADAĞ KARAKULAK E., et al.

TURKISH JOURNAL OF MEDICAL SCIENCES , cilt.49, sa.4, ss.985-992, 2019 (SCI-Expanded, Scopus, TRDizin)

18. The impact of JAK/STAT inhibitor ruxolitinib on the genesis of lymphoproliferative diseases

Turk C., OKAY M., TÜRK S., Temirci E. S., Javad O., AKSU S., et al.

TURKISH JOURNAL OF MEDICAL SCIENCES , cilt.49, sa.2, ss.661-674, 2019 (SCI-Expanded, Scopus, TRDizin)

19. Aggressive Clinicopathological Course of Myeloma with t(3;16) (q21;q22) Cytogenetic Abnormality

Bozkurt S., OKAY M., Haznedaroglu I.

TURKISH JOURNAL OF HEMATOLOGY , cilt.36, sa.1, ss.62-63, 2019 (SCI-Expanded, Scopus, TRDizin)

20. HEMATOLOGICAL NEOPLASTIC DISORDERS WITH CHROMOSOME 3 ABNORMALITIES

Bozkurt S., OKAY M., Saglam F., Haznedaroglu C. I.

ACTA MEDICA MEDITERRANEA , cilt.35, sa.5, ss.2703-2707, 2019 (SCI-Expanded, Scopus)

21. Tumor Lysis Syndrome Due to Targeting of Hepatocellular Carcinoma Associated with Chronic Myelomonocytic Leukemia

OKAY M., ÇETİK S., HAZNEDAROĞLU İ. C.

TURKISH JOURNAL OF HEMATOLOGY , cilt.36, sa.3, ss.218-219, 2019 (SCI-Expanded, Scopus, TRDizin)

22. Effect of postremission high dose cytarabine-based consolidation chemotherapy before allogenic stem cell transplantation in outcomes of acute myeloid leukemia patients

CIFTCILER R., DEMİROĞLU H., BÜYÜKAŞIK Y., OKAY M., AKSU S., Sayinalp N., et al.

TRANSFUSION AND APHERESIS SCIENCE , cilt.57, sa.6, ss.752-755, 2018 (SCI-Expanded, Scopus)

23. Evaluation of Secondary Malignancies in Chronic Lymphocytic Leukemia

DEMİROĞLU H., SAYINALP N., GÖKER H., BÜYÜKAŞIK Y., ÖZCEBE O. İ., HAZNEDAROĞLU İ. C., et al.

Journal of Global Oncology , ss.205, 2018 (ESCI)

24. Pediatric Chemotherapeutic Regimen (BFM-95) is Superior for Overall Survival in Adult Acute Lymphoblastic Leukemia

KARCIOĞLU A. M., OKAY M., BÜYÜKAŞIK Y., Malkan Ü. Y., SAYINALP N., DEMİROĞLU H., et al.

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , cilt.28, sa.4, ss.254-260, 2018 (SCI-Expanded, Scopus, TRDizin)

25. The impact of chemo/immune therapy-related cytopenias on the clinical course of chronic lymphoid leukemia

Malkan Ü. Y., OKAY M., HAZNEDAROĞLU İ. C., GÜNEŞ G., Aslan N. A., ÖZCEBE O. İ., et al.

LEUKEMIA & LYMPHOMA , cilt.58, ss.96, 2017 (SCI-Expanded)

Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 19

1. EARLY CESSATION OF EMPIRICAL ANTIBACTERIAL THERAPY IN HIGH-RISK FEBRILE NEUTROPENIC PATIENTS WITH FEVER OF UNKNOWN ORIGIN (FUO)

KORUCU B., İNKAYA A. Ç., ERBİL A., OKAY M., AŞÇIOĞLU S., TOKUÇOĞLU ALTUNAY H., et al.

20TH SYMPOSIUM ON INFECTIONS IN THE IMMUNOCOMPROMISED HOST, ATİNA, Yunanistan, 17 - 19 Temmuz 2019, ss.76, (Özet Bildiri)

2. Incidence and risk factors for hepatic sinusoidal obstruction syndrome after allogeneic transplantation: Retrospective multicenter study of Turkish hematology research and education group (THREG), updated data

SOYER N., Gunduz M., Tekgunduz E., Deveci B., Ozdogu H., ŞAHİN H. H., et al.

45th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT), Frankfurt, Almanya, 24 - 27 Mart 2019, cilt.54, ss.254-255, (Özet Bildiri)

3. T HÜCRELİ LENFOMA HASTALARININ KLİNİK ÖZELLİKLERİNİN DEĞERLENDİRİLMESİ: TANIDAN PROGNOZA TEK MERKEZ DENEYİMİ

DEMİROĞLU H., SAYINALP N., GÖKER H., BÜYÜKAŞIK Y., ÖZCEBE O. İ., HAZNEDAROĞLU İ. C., et al.

TÜRK HEMATOLOJİ DERNEĞİ, Türkiye, 31 Ekim - 03 Kasım 2018, (Tam Metin Bildiri)

4. PHILADELPHIA KROMOZOMU POZİTİF AKUT MYELOİD LÖSEMİLİ OLGU

DEMİROĞLU H., GÖKER H., BÜYÜKAŞIK Y., ÇİFTÇİLER R., ALADAĞ KARAKULAK E., OKAY M.

TÜRK HEMATOLOJİ DERNEĞİ, Türkiye, 31 Ekim - 03 Kasım 2018, (Tam Metin Bildiri)

5. BRENTIXUMAB VEDOTIN IN CD30 LYMPHOMAS: SINGLE CENTER EXPERIENCE

DEMİROĞLU H., SAYINALP N., BÜYÜKAŞIK Y., ÖZCEBE O. İ., HAZNEDAROĞLU İ. C., GÖKER H., et al.

IX. INTERNATIONAL EHOC, 17 - 20 Ekim 2018, cilt.73, (Tam Metin Bildiri)

6. Descriptive analysis of myeloproliferative diseases and its complications

OKAY M., MALKAN Ü. Y., BÖLEK E. Ç., Aladag E., HAZIYEV T., SAYINALP N., et al.

9th International Eurasian Hematology Oncology Congress (EHOC), İstanbul, Türkiye, 17 - 20 Ekim 2018, cilt.73, (Özet Bildiri)

7. Mitoxantrone-melphalan conditioning regimen for autologous stem cell transplantation in relapsed/refractory lymphoma

OKAY M., BÜYÜKAŞIK Y., DEMİROĞLU H., MALKAN Ü. Y., CIFTCILER R., Aladag E., et al.

9th International Eurasian Hematology Oncology Congress (EHOC), İstanbul, Türkiye, 17 - 20 Ekim 2018, cilt.73, (Özet Bildiri)

8. RELAPS/REFRAKTER LENFOMADA OTOLOG KÖK HÜCRE TRANSPLANTASYONUNDA MİTOKSANNTRON-MELFALAN HAZIRLAMA REJİMİ

OKAY M., BÜYÜKAŞIK Y., DEMİROĞLU H., malkan Ü. Y., ÇİFTÇİLER R., ALADAĞ KARAKULAK E., et al.

6. HEMATOLOJİK ONKOLOJİ KONGRESİ, Türkiye, 18 - 22 Eylül 2018, (Tam Metin Bildiri)

9. COMPARISON OF MYELOABLATIVE AND REDUCED-INTENSITY CONDITIONING REGIMENS FOR ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN PATIENTS WITH ACUTE MYELOID LEUKEMIA

ÇİFTÇİLER R., OKAY M., ALADAĞ KARAKULAK E., BÜYÜKAŞIK Y., GÖKER H., DEMİROĞLU H.

EUROPEAN HEMATOLOGY ASSOCIATION, 14 - 17 Haziran 2018, (Tam Metin Bildiri)

10. Echocardiographic Evaluation of Patients with Hodgkin and Non Hodgkin Lymphoma before and after Hematopoietic Stem Cell Transplantation

KELKİTLİ E., BÜYÜKAŞIK Y., DEMİROĞLU H., ŞAHİNER M. L., OKAY M., AYDIN M. S., et al.

59th ASH, 9 - 12 Aralık 2017, cilt.130, ss.5521, (Özet Bildiri)

11. Donor Lymphocyte Infusions: Single Center Experience

KELKİTLİ E., GÖKER H., TURGUT M., DEMİROĞLU H., SAYINALP N., AKSU S., et al.

LYMPHOMAMYELOMA 2017, New York, Amerika Birleşik Devletleri, 26 - 28 Kasım 2017, cilt.1, ss.48, (Özet Bildiri)

12. Prognosis of Multiple Myeloma in Younger Patients Who Are Undergoing Upfront Autologuous Stem Cell Transplantation

KELKİTLİ E., GÖKER H., DEMİROĞLU H., TURGUT M., OKAY M., SAYINALP N., et al.

LYMPHOMA AND MYELOMA 2017, New York, Amerika Birleşik Devletleri, 26 - 28 Kasım 2017, cilt.1, ss.43-44, (Özet Bildiri)

13. Erken Evre Kronik Lenfositer Löseminin Nadir Görünümleri ve Bir Mide Kanseri Vakası Birlikteliği: 2 vaka sunumu.

AYDIN M. S., ÜNER A., OKAY M., MALKAN Ü. Y., BÜYÜKAŞIK Y., ÖZCEBE O. İ., et al.

43. ULUSAL HEMATOLOJİ KONGRESİ, Antalya, Türkiye, 31 Ekim - 05 Kasım 2017, cilt.1, ss.66, (Özet Bildiri) Sürdürülebilir Kalkınma

14. Donor Lymhocyte Infusion: Single Center Experience

KELKİTLİ E., GÖKER H., TURGUT M., Demiroğlu H., SAYINALP N., AKSU S., et al.

LYMHOMA MYELOMA 2017, 26 - 28 Ekim 2017, (Özet Bildiri)

15. Monoclonhal gammopathy of renal significance presenting as monotypic plasma cell interststial nephritis in two patients with Sjogren’xxs Syndrome

Balaban S., AYHAN E. A., ÜNER A., OKAY M., BÜYÜKAŞIK Y.

7. Uluslararası Avrasya Hematoloji Kongresi, 13 - 16 Ekim 2017, cilt.61, ss.15, (Özet Bildiri)

16. RARE PRESENTATIONS OF EARLY STAGE CHRONIC LYMPHOCYTIC LEUKEMIA AND A COINCIDENCE WITH GASTRIC CANCER: 2 CASES

AYDIN M. S., ÜNER A., malkan Ü. Y., OKAY M., BÜYÜKAŞIK Y., ÖZCEBE O. İ., et al.

LEUKEMIA RESEARCH, İstanbul, Türkiye, 18 - 21 Ekim 2017, cilt.61, ss.16, (Özet Bildiri) Sürdürülebilir Kalkınma

17. MONOCLONAL GAMMOPATHY OF RENAL SIGNIFICANCE PRESENTING AS MONOTYPIC PLASMA CELL INTERTISTIAL NEPHRITIS IN TWO PATIENTS WITH SJÖGREN’S SYNDROME

AYDIN M. S., sağlam a., ÜNER A., OKAY M., BÜYÜKAŞIK Y.

VIII.EURASIAN HEMATOLOGY ONCOLOGY CONGRESS, İstanbul, Türkiye, 18 - 21 Ekim 2017, cilt.61, ss.16, (Özet Bildiri)

18. BRONŞİEKTAZİ İLE PREZENTE OLAN BİR YAYGIN DEĞİŞKEN İMMÜN YETMEZLİĞİ (CVID) VAKASI

HOUSSEİN M., ARMAĞAN B., ÇALIK BAŞARAN N., KÖKSAL D., OKAY M., ÇAĞDAŞ AYVAZ D. N., et al.

19.ULUSAL İÇ HASTALIKLARI KONGRESİ, Antalya, Türkiye, 11 - 15 Ekim 2017, (Özet Bildiri)

19. The Impact of Chemo/Immune Therapy-‐Related Cytopeniason the Clinical Course of Chronic Lymphoid Leukemia

OKAY M., HAZNEDAROĞLU İ. C., malkan Ü. Y., GÜNEŞ G., aslan n., AKSU S., et al.

iwcll2017, New York, Amerika Birleşik Devletleri, 12 - 15 Mayıs 2017, (Özet Bildiri)

Metrikler

Yayın

Yayın (WoS)

Yayın (Scopus)

Atıf (WoS)

H-İndeks (WoS)

Atıf (Scopus)

H-İndeks (Scopus)

Atıf (TrDizin)

H-İndeks (TrDizin)

Atıf (Diğer Toplam)

Proje

Açık Erişim

BM Sürdürülebilir Kalkınma Amaçları

Yayınlar & Eserler